Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Share buyback programme

14 Feb 2022 07:00

RNS Number : 5097B
Johnson Matthey PLC
14 February 2022
 

14th February 2022

 

Johnson Matthey Plc

Share buyback programme

 

On 24th November 2021, Johnson Matthey Plc ("JM" or the "Company") announced its intention to conduct a share buyback programme of its ordinary shares up to a maximum consideration of £200m.

 

The first tranche of the share buyback programme of up to £100m commenced on 21st December 2021 and completed on 28th January 2022, in accordance with its terms.

 

The Company announces that the second tranche of the share buyback programme of up to £100m (the "Programme") will commence today and will end no later than 20th May 2022.

The Company has entered into an irrevocable, non-discretionary agreement with Citigroup Global Markets Ltd ("Citi") to manage the Programme, pursuant to which Citi will purchase Johnson Matthey ordinary shares (acting as principal) for subsequent repurchase by the Company. Citi will make trading decisions under the Programme independently of JM. Purchases may continue during any closed period to which the Company is subject.

 

The sole purpose of the Programme is to reduce the share capital of the Company. All shares repurchased under the Programme will be cancelled.

 

The maximum number of shares that may be repurchased under the Programme is 19,353,343 shares, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2021 Annual General Meeting (the "2021 AGM"), less the number of shares that have already been repurchased pursuant to that authority.

Any purchase of the Company's ordinary shares in relation to this announcement will be effected within certain pre-set parameters and in accordance with JM's general authority to repurchase ordinary shares granted by its shareholders at the 2021 AGM, the Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), and Chapter 12 of the Financial Conduct Authority's Listing Rules. No repurchases will be made in respect of the Company's American Depositary Receipts.

 

ENDS

 

Enquiries: 

 

 

 

Martin Dunwoodie

Victoria Barlow

 

Director of Investor Relations

Deputy Company Secretary

 

+44 20 7269 8241

+44 20 7269 8431

 

 

 

 

 

 

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKNBDKBKBNBD
Date   Source Headline
15th Aug 20242:35 pmRNSHolding(s) in Company
15th Aug 20242:25 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20242:47 pmRNSHolding(s) in Company
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 202412:58 pmRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20244:01 pmRNSHolding(s) in Company
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20249:16 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 202410:55 amRNSHolding(s) in Company
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20244:18 pmRNSDirector/PDMR Shareholding
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:35 pmRNSHolding(s) in Company
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202412:53 pmRNSHolding(s) in Company
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20244:25 pmRNSDirector/PDMR Shareholding
18th Jul 202412:46 pmRNSResult of AGM
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 202410:34 amRNSHolding(s) in Company
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20245:06 pmRNSHolding(s) in Company
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20243:24 pmRNSHolding(s) in Company
3rd Jul 20247:00 amRNSShare buyback programme
2nd Jul 20243:04 pmRNSHolding(s) in Company
1st Jul 20242:38 pmRNSCompletion of Medical Device Components sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.